AAAAAA

   
Results: 1-10 |
Results: 10
THE ROUTINE DETERMINATION OF THE ENDOGENOUS THROMBIN POTENTIAL, FIRSTRESULTS IN DIFFERENT FORMS OF HYPERCOAGULABILITY AND HYPOCOAGULABILITY
Authors: WIELDERS S MUKHERJEE M MICHIELS J RIJKERS DTS CAMBUS JP KNEBEL RWC KAKKAR V HEMKER HC BEGUIN S
Citation: S. Wielders et al., THE ROUTINE DETERMINATION OF THE ENDOGENOUS THROMBIN POTENTIAL, FIRSTRESULTS IN DIFFERENT FORMS OF HYPERCOAGULABILITY AND HYPOCOAGULABILITY, Thrombosis and haemostasis, 77(4), 1997, pp. 629-636
ANTIDEPRESSANT DRUGS IN DISEASES OTHER THAN MENTAL DEPRESSION
Authors: KULKARNI SK NINAN I GUPTA YK KAKKAR V
Citation: Sk. Kulkarni et al., ANTIDEPRESSANT DRUGS IN DISEASES OTHER THAN MENTAL DEPRESSION, Medicamentos de actualidad, 33(6), 1997, pp. 359-369
COAGULATION-FACTOR ABNORMALITIES AFTER THE FONTAN PROCEDURE AND ITS MODIFICATIONS
Authors: JAHANGIRI M SHORE D KAKKAR V LINCOLN C SHINEBOURNE E
Citation: M. Jahangiri et al., COAGULATION-FACTOR ABNORMALITIES AFTER THE FONTAN PROCEDURE AND ITS MODIFICATIONS, Journal of thoracic and cardiovascular surgery, 113(6), 1997, pp. 989-992
CONVERSION OF PROTHROMBIN TO AN ENZYMATICALLY AND MITOGENICALLY ACTIVE FORM AT THE SURFACE OF HUMAN VASCULAR SMOOTH-MUSCLE CELLS
Authors: KANTHOU C DENNEHY U BENZAKOU O KAKKAR V
Citation: C. Kanthou et al., CONVERSION OF PROTHROMBIN TO AN ENZYMATICALLY AND MITOGENICALLY ACTIVE FORM AT THE SURFACE OF HUMAN VASCULAR SMOOTH-MUSCLE CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 911-911
ENHANCEMENT OF THE SPECIFICITY OF PEPTIDE BOROISOTHIOURONIUM INHIBITOR OF THROMBIN
Authors: DEADMAN J GOODWIN C ELGENDY S CHINO N SCULLY M KAKKAR V
Citation: J. Deadman et al., ENHANCEMENT OF THE SPECIFICITY OF PEPTIDE BOROISOTHIOURONIUM INHIBITOR OF THROMBIN, Thrombosis and haemostasis, 73(6), 1995, pp. 925-925
THROMBIN INDUCES A PARTIAL RELEASE AND REDISTRIBUTION OF TISSUE FACTOR PATHWAY INHIBITOR BY HUMAN ENDOTHELIAL-CELLS
Authors: LUPU C LUPU F KAKKAR V SCULLY M
Citation: C. Lupu et al., THROMBIN INDUCES A PARTIAL RELEASE AND REDISTRIBUTION OF TISSUE FACTOR PATHWAY INHIBITOR BY HUMAN ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 933-933
CLINICAL-SIGNIFICANCE OF HEPARIN COFACTOR-II (HCII) IN PATIENTS TREATED WITH PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
Authors: VAIDYANATHAN I MELISSARI E KAKKAR V
Citation: I. Vaidyanathan et al., CLINICAL-SIGNIFICANCE OF HEPARIN COFACTOR-II (HCII) IN PATIENTS TREATED WITH PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), Thrombosis and haemostasis, 73(6), 1995, pp. 1043-1043
LOCALIZATION OF TISSUE FACTOR PATHWAY INHIBITOR IN NORMAL AND ATHEROSCLEROTIC VESSELS
Authors: LUPU F LUPU C SCULLY M DAS S KAKKAR V
Citation: F. Lupu et al., LOCALIZATION OF TISSUE FACTOR PATHWAY INHIBITOR IN NORMAL AND ATHEROSCLEROTIC VESSELS, Thrombosis and haemostasis, 73(6), 1995, pp. 1184-1184
CRYSTALLIZATION TEST FOR THE DETECTION OF HEAD AND NECK-CANCER
Authors: GULATI SP SACHDEVA OP SACHDEVA A ADLAKHA RP KAKKAR V
Citation: Sp. Gulati et al., CRYSTALLIZATION TEST FOR THE DETECTION OF HEAD AND NECK-CANCER, ORL, 56(5), 1994, pp. 283-286
NASAL MUCOCILIARY CLEARANCE AND MUCUS PH IN PATIENTS WITH DIABETES-MELLITUS
Authors: SACHDEVA A SACHDEVA OP GULATI SP KAKKAR V
Citation: A. Sachdeva et al., NASAL MUCOCILIARY CLEARANCE AND MUCUS PH IN PATIENTS WITH DIABETES-MELLITUS, Indian journal of medical research. Section B: Biomedical research other than infectious diseases, 98, 1993, pp. 265-268
Risultati: 1-10 |